Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Silent myocardial ischemia--classification and management.

¹State University of New York, Stony Brook.

Hospital Practice (Office Ed.)

|February 28, 1990

Summary

Up to 10% of middle-aged men have silent coronary artery disease. Medications used for angina also appear effective for silent ischemic episodes, suggesting a unified treatment approach for cardiac conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

External counterpulsation for the treatment of myocardial ischemia.

Heart disease (Hagerstown, Md.)·2001

Same author

Medical treatment of silent myocardial ischemia.

Heart disease (Hagerstown, Md.)·2001

Same author

Acute hemodynamic effects and angina improvement with enhanced external counterpulsation.

Angiology·2001

Same author

The value of continuous ST segment monitoring in patients with unstable angina.

European heart journal·2001

Same author

Direct coronary stenting without balloon or device pretreatment: acute success and long-term results.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2001

Same author

EECP -- new data on possible mechanisms of action.

European heart journal·2001

Area of Science:

Cardiology
Internal Medicine
Public Health

Background:

Coronary artery disease (CAD) affects a significant portion of the middle-aged male population.
Silent, or asymptomatic, CAD represents a substantial and often undiagnosed health concern.
Patients may present with silent ischemia post-myocardial infarction or alongside angina.

Observation:

Silent and symptomatic episodes of myocardial ischemia share comparable hemodynamic and electrical characteristics.
The presence of silent disease is common, affecting up to 10% of middle-aged men.
These silent episodes are as active as symptomatic ones.

Findings:

Antianginal medications demonstrate broad efficacy in managing ischemic events.
Therapeutic interventions for angina may provide global anti-ischemic benefits.
Silent ischemia and angina share underlying physiological mechanisms.

Implications:

This suggests a potential for unified therapeutic strategies for both silent and symptomatic coronary artery disease.
Early detection and management of silent CAD are crucial for preventing adverse cardiovascular events.
Further research into the long-term impact of antianginal medications on silent ischemia is warranted.

Related Experiment Videos